Corteva, Inc. (CTVA) Stock: Price, Forecast & Analyst Target
Corteva, Inc. (CTVA) — MoonshotScore 51/100 (Fair band), calculated Nov 18, 2026. Price $8.12 (-2.87%), as of the Nov 19, 2026 trading session; market cap $5.42B. Expected results Feb 2, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Corteva, Inc. · CTVA · NYSE · Basic Materials · Agricultural Inputs
Research dated 2026-09-12: Corteva sells seed genetics, traits, crop-protection products and farm decision tools, making farmer product selection and crop-protection demand more important than the broad agricultural-input label suggests. Its case rests on whether rising operating profit can endure when revenue softens and seasonal cash conversion weakens.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Corteva (CTVA)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Cheap, but the fundamentals are only middling. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and reported profit not backed by cash flow. Business Quality: Solid; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Flat; Momentum: Quiet.
- EPS beat 6 of the last 8 reports
- expected results Feb 2, 2027
- Altman Z 0.94 · Piotroski F 5
Helping: an attractive price
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 83 | Exceptional | |
| 75 | Strong | |
| 54 | Fair | |
| 54 | Fair | |
| 51 | Fair | |
| 51 | Fair |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $8.12 | |
| Change on the day | -2.87% | |
| 52-week range | $8.12–$14.62 | |
| Market capitalisation | $5.42B | — |
| Price / earnings (trailing) | 7.29 | |
| Shares traded on the day | 19.97M | |
| Beta (volatility vs the S&P 500) | 0.59 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Corteva (CTVA): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Corteva (CTVA), and what does it report?
Short answer · as of
Seed revenue comes from germplasm and traits designed around yield, weather, disease, insects and herbicide resistance; Crop Protection supplies herbicides, insecticides, fungicides, nitrogen stabilizers and seed-applied technologies.
Research dated 2026-09-12.
Digital tools support product selection rather than forming the core reported business.
Seed contributes the larger revenue base, while Crop Protection supplies a substantial complementary stream. Quarterly revenue, profit and cash flow swing markedly across the agricultural selling cycle, so an isolated period can give a distorted view of underlying economics.
What do the latest results show for Corteva (CTVA)?
Research dated 2026-09-12.
The latest reported period paired a modest revenue decline with lower gross profit and net income, yet operating profit increased. That improvement therefore appeared below gross profit rather than through sales acceleration; research and selling expenses shown in the statement did not decline.
Reported earnings exceeded the market estimate while revenue fell short, reversing the prior period’s combination of revenue and earnings outperformance. Across the latest annual record, revenue and net income improved, but the recent quarterly pattern remains uneven rather than a clean acceleration.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
| Sep 30, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Jun 2025 | $6.46B | $1.31B | — |
| Sep 2025 | $2.62B | -$320M | -$0.47 (diluted) |
| Q4 FY2025 | $3.91B | -$552M | -$0.82 (diluted) |
| Q1 FY2026 | $4.91B | $720M | $1.07 (diluted) |
What are the financial strengths and risks for Corteva (CTVA)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
Cash and investments do not cover total debt, although reported liquidity ratios indicate adequate near-term coverage and leverage remains modest relative to equity. The balance sheet therefore has flexibility, but it is not a net-cash cushion.
Cash generation is sharply seasonal, with heavy outflows near the opening of the annual cycle and large inflows near year-end. The latest midyear period remained cash-flow negative after the comparable period had turned positive, even though the cash balance finished only modestly below its level at the start of the reported window.
A thin free-cash-flow yield, modest returns on assets and equity, and a demanding earnings multiple leave the valuation dependent on continued profit improvement. Weak farmer demand would pressure Seed and Crop Protection through the same agricultural purchasing cycle.
What should you watch next at Corteva (CTVA)?
Short answer · as of
The next earnings report is expected on Feb 2, 2027.
Research dated 2026-09-12.
Corteva’s next scheduled report arrives in a seasonally weaker part of its reporting cycle, with consensus anticipating a loss and revenue near the recent trough range. The useful checks are whether revenue holds above the prior seasonal low, whether operating-profit resilience survives softer volume, and whether cash begins its customary recovery.
Longer-range estimates imply gradual revenue and earnings expansion rather than an abrupt change in scale. Progress would look more convincing if earnings gains remain accompanied by revenue growth and a renewed year-end cash inflow.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does Corteva compare with its peers?
Short answer
Corteva's score ranks 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Corteva is not simply a commodity chemical supplier. Its larger Seed operation monetizes germplasm and traits, while Crop Protection sells chemistry and seed-applied technologies; digital selection tools connect those offerings to farm decisions.
That portfolio gives Corteva exposure to intellectual property in seed as well as recurring crop-protection demand, supported by rising research spending. A pure seed or pesticide business lacks this same operating mix, while Corteva must fund innovation across the combined portfolio.
| Company | Price | Market value | Score |
|---|---|---|---|
| $77.01 Nov 19, 2026 | $39.0B | 99 5-pillar Nov 18, 2026 | |
| $113.70 Nov 18, 2026 | $16.6B | 98 5-pillar Nov 18, 2026 | |
| $120.27 Nov 18, 2026 | $54.6B | 91 5-pillar Nov 18, 2026 | |
| $247.43 Nov 19, 2026 | $55.7B | 85 5-pillar Nov 18, 2026 | |
| $29.50 Nov 19, 2026 | $394M | 77 5-pillar Nov 18, 2026 | |
| $95.93 Nov 19, 2026 | $1.10B | 70 5-pillar Nov 18, 2026 | |
| $65.41 Nov 19, 2026 | $31.0B | 70 5-pillar Nov 18, 2026 | |
| $4.14 Nov 19, 2026 | $5.69B | 62 5-pillar Nov 18, 2026 | |
| $9.83 Nov 19, 2026 | $41.8B | 60 5-pillar Nov 18, 2026 | |
| $61.38 Nov 19, 2026 | $3.57B | 58 5-pillar Nov 18, 2026 | |
| $303.83 Nov 19, 2026 | $67.7B | 53 5-pillar Nov 18, 2026 | |
| Corteva (CTVA) — this page | $8.12 | $5.42B | 51 |
| $7.95 Nov 18, 2026 | $2.21B | 42 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $11.00 – $101.00
- Consensus target
- $30.45
- Median target
- $17.00
Consensus record · Captured .
Measured against a quoted price of $8.12 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 16, 2026
- Transactions
- 17
- Identified insiders
- 8
- Purchases
- 3
- Sales
- 0
- Other transactions
- 14
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CTVA in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0% | $0 | Sold out (was $20.58M) |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Corteva (CTVA)?
CTVA Basic Materials Stock FAQ
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does Corteva sell beyond crop-protection chemicals?
Corteva develops seed germplasm and traits for yield, resistance and nutritional characteristics, alongside digital tools that help farmers select products. Seed contributes more revenue than Crop Protection.
Why can Corteva report profit while operating cash flow is negative?
Accounting profit and cash timing diverge sharply across Corteva’s agricultural cycle. Recent history shows heavy cash outflows near the cycle’s opening and substantial inflows near year-end, even while reported earnings remain positive in some outflow periods.
Is Corteva’s Seed business larger than Crop Protection?
Seed supplies the larger share of segment revenue, with Crop Protection providing the complementary chemistry and seed-applied portfolio. That mix makes Corteva more than a pesticide producer.
Can Corteva sustain operating leverage through its seasonal low?
The latest period showed higher operating profit despite softer revenue and gross profit, but cash conversion weakened. Confirmation would require that profit resilience persist through the expected seasonal trough and that cash generation recover near year-end.
What is the CTVA stock price today?
The last price recorded for Corteva, Inc. (CTVA), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CTVA price target?
The analyst consensus price target for Corteva, Inc. (CTVA), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 24 figures on this page — 1 from SEC filings and earnings calls, 18 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold CTVA
Funds in our ETF coverage that list CTVA among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| FTAG ETF | 9.44% | |
| First Trust Indxx Global Natural Resources Income ETF (FTRI) | 9.28% | |
| T. Rowe Price Natural Resources ETF (TURF) | 5.38% |